• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Characterization and use of a rabbit-anti-mouse VPAC1 antibody by flow cytometry.流式细胞术鉴定和应用兔抗鼠 VPAC1 抗体。
J Immunol Methods. 2012 Feb 28;376(1-2):20-31. doi: 10.1016/j.jim.2011.10.009. Epub 2011 Nov 4.
2
Screening of a specific peptide binding to VPAC1 receptor from a phage display peptide library.从噬菌体展示肽文库中筛选与 VPAC1 受体特异性结合的肽。
PLoS One. 2013;8(1):e54264. doi: 10.1371/journal.pone.0054264. Epub 2013 Jan 24.
3
Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine.血管活性肠肽主要受体VPAC1在肠道全长中的表达及定位
Am J Physiol Gastrointest Liver Physiol. 2017 Jul 1;313(1):G16-G25. doi: 10.1152/ajpgi.00081.2017. Epub 2017 Apr 6.
4
Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.垂体腺苷酸环化酶激活多肽及PACAP受体在大鼠肾上腺中的表达与功能
Int J Mol Med. 2002 Mar;9(3):233-43.
5
Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells.人T细胞中血管活性肠肽1型和2型受体的选择性基因表达及激活依赖性调控
J Immunol. 2001 Feb 15;166(4):2522-30. doi: 10.4049/jimmunol.166.4.2522.
6
A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.一种具有血管活性肠肽VPAC1激动剂活性和VPAC2拮抗剂作用的淋巴细胞生成片段。
J Pharmacol Exp Ther. 2003 Aug;306(2):638-45. doi: 10.1124/jpet.103.050583. Epub 2003 May 15.
7
VPAC1 receptor expression in peripheral blood mononuclear cells in a human endotoxemia model.在人类内毒素血症模型中,外周血单个核细胞中 VPAC1 受体的表达。
J Transl Med. 2013 May 7;11:117. doi: 10.1186/1479-5876-11-117.
8
Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents.VPAC1和VPAC2受体参与啮齿动物压力诱导的血管舒张的证据。
J Physiol. 2004 Jan 15;554(Pt 2):519-28. doi: 10.1113/jphysiol.2003.053835. Epub 2003 Oct 24.
9
A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.克隆的蛙血管活性肠肽/垂体腺苷酸环化酶激活肽受体具有哺乳动物中VPAC1和VPAC2受体的药理学及组织分布特征。
Endocrinology. 1999 Mar;140(3):1285-93. doi: 10.1210/endo.140.3.6576.
10
Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis.早期淋巴发生过程中血管活性肠肽 (VIP) 受体的激进逆转。
Peptides. 2011 Oct;32(10):2058-66. doi: 10.1016/j.peptides.2011.08.014. Epub 2011 Aug 22.

引用本文的文献

1
CREB-regulated transcription during glycogen synthesis in astrocytes.星形胶质细胞中糖原合成时的 CREB 调节转录。
Sci Rep. 2024 Aug 2;14(1):17942. doi: 10.1038/s41598-024-67976-w.
2
Chemical Modifications to Enhance the Drug Properties of a VIP Receptor Antagonist (ANT) Peptide.化学修饰以增强血管活性肠肽(VIP)受体拮抗剂(ANT)肽的药物特性
Int J Mol Sci. 2024 Apr 16;25(8):4391. doi: 10.3390/ijms25084391.
3
Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia.在急性白血病小鼠模型中,给予血管活性肠肽拮抗剂可增强自体抗白血病T细胞反应。
Oncoimmunology. 2017 Mar 16;6(5):e1304336. doi: 10.1080/2162402X.2017.1304336. eCollection 2017.
4
VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.血管活性肠肽1型受体(Vipr1)缺陷小鼠表现出实验性自身免疫性脑脊髓炎症状改善,在效应阶段存在特定缺陷。
J Neuroinflammation. 2016 Jun 29;13(1):169. doi: 10.1186/s12974-016-0626-3.

本文引用的文献

1
Identification of the early VIP-regulated transcriptome and its associated, interactome in resting and activated murine CD4 T cells.鉴定静息和激活的小鼠 CD4 T 细胞中早期 VIP 调控的转录组及其相关的相互作用组。
Mol Immunol. 2010 Mar;47(6):1181-94. doi: 10.1016/j.molimm.2010.01.003. Epub 2010 Feb 1.
2
Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide.血管活性肠肽诱导同种异体抗原特异性人调节性T细胞
J Immunol. 2009 Oct 1;183(7):4346-59. doi: 10.4049/jimmunol.0900400. Epub 2009 Sep 4.
3
A transcriptionally permissive epigenetic landscape at the vasoactive intestinal peptide receptor-1 promoter suggests a euchromatin nuclear position in murine CD4 T cells.血管活性肠肽受体-1启动子处转录允许的表观遗传格局表明其在小鼠CD4 T细胞中处于常染色质核位置。
Regul Pept. 2009 Nov 27;158(1-3):68-76. doi: 10.1016/j.regpep.2009.08.010. Epub 2009 Sep 1.
4
Alternative splicing of G protein-coupled receptors: physiology and pathophysiology.G蛋白偶联受体的可变剪接:生理学与病理生理学
Cell Mol Life Sci. 2009 Oct;66(20):3337-52. doi: 10.1007/s00018-009-0093-4. Epub 2009 Jul 23.
5
Stimulatory and suppressive signal transduction regulates vasoactive intestinal peptide receptor-1 (VPAC-1) in primary mouse CD4 T cells.刺激和抑制信号转导调节原代小鼠CD4 T细胞中的血管活性肠肽受体-1(VPAC-1)。
Brain Behav Immun. 2008 Oct;22(7):1024-1031. doi: 10.1016/j.bbi.2008.04.006. Epub 2008 Jun 13.
6
TCR signaling and environment affect vasoactive intestinal peptide receptor-1 (VPAC-1) expression in primary mouse CD4 T cells.TCR信号传导和环境影响原代小鼠CD4 T细胞中血管活性肠肽受体-1(VPAC-1)的表达。
Brain Behav Immun. 2008 Oct;22(7):1032-1040. doi: 10.1016/j.bbi.2008.04.005. Epub 2008 Jun 4.
7
Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.血管活性肠肽受体与类风湿关节炎的遗传关联:免疫细胞中表达和信号的改变
Arthritis Rheum. 2008 Apr;58(4):1010-9. doi: 10.1002/art.23482.
8
PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer.实验性和自发性前列腺癌中VPAC1表达的正电子发射断层扫描(PET)成像
J Nucl Med. 2008 Jan;49(1):112-21. doi: 10.2967/jnumed.107.043703. Epub 2007 Dec 12.
9
PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications.垂体腺苷酸环化酶激活肽及其受体VPAC1调节巨核细胞成熟:治疗意义。
Blood. 2008 Feb 15;111(4):1885-93. doi: 10.1182/blood-2007-06-098558. Epub 2007 Nov 13.
10
The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics.血管活性肠肽(VIP)从α螺旋直至C末端与人类VIP/垂体腺苷酸环化酶激活肽1型受体的N端胞外域相互作用:光亲和性、分子建模及动力学研究
Mol Endocrinol. 2008 Jan;22(1):147-55. doi: 10.1210/me.2007-0361. Epub 2007 Sep 20.

流式细胞术鉴定和应用兔抗鼠 VPAC1 抗体。

Characterization and use of a rabbit-anti-mouse VPAC1 antibody by flow cytometry.

机构信息

Department of Chemistry and Molecular Biology and the Center for Protease Research, North Dakota State University, Fargo, ND 58108-6050, United States.

出版信息

J Immunol Methods. 2012 Feb 28;376(1-2):20-31. doi: 10.1016/j.jim.2011.10.009. Epub 2011 Nov 4.

DOI:10.1016/j.jim.2011.10.009
PMID:22079255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3273623/
Abstract

Vasoactive intestinal peptide receptor-1 signaling in lymphocytes has been shown to regulate chemotaxis, proliferation, apoptosis and differentiation. During T cell activation, VPAC1 mRNA is downregulated, but the effect on its protein levels is less clear. A small number of studies have reported measurement of human VPAC1 by flow cytometry, but murine VPAC1 reagents are unavailable. Therefore, we set out to generate a reliable and highly specific α-mouse VPAC1 polyclonal antibody for use with flow cytometry. After successfully generating a rabbit α-VPAC1 polyclonal antibody (α-mVPAC1 pAb), we characterized its cross-reactivity and showed that it does not recognize other family receptors (mouse VPAC2 and PAC1, and human VPAC1, VPAC2 and PAC1) by flow cytometry. Partial purification of the rabbit α-VPAC1 sera increased the specific-activity of the α-mVPAC1 pAb by 20-fold, and immunofluorescence microscopy (IF) confirmed a plasma membrane subcellular localization for mouse VPAC1 protein. To test the usefulness of this specific α-mVPAC1 pAb, we showed that primary, resting mouse T cells express detectable levels of VPAC1 protein, with little detectable signal from activated T cells, or CD19 B cells. These data support our previously published data showing a downregulation of VPAC1 mRNA during T cell activation. Collectively, we have established a well-characterized, and highly species specific α-mVPAC1 pAb for VPAC1 surface measurement by IF and flow cytometry.

摘要

血管活性肠肽受体-1(VPAC1)信号在淋巴细胞中被证明可以调节趋化性、增殖、凋亡和分化。在 T 细胞激活过程中,VPAC1mRNA 下调,但对其蛋白水平的影响尚不清楚。少数研究报道了使用流式细胞术测量人 VPAC1,但鼠 VPAC1 试剂不可用。因此,我们着手生成一种可靠且高度特异性的α-鼠 VPAC1 多克隆抗体,用于流式细胞术。在成功生成兔α-VPAC1 多克隆抗体(α-mVPAC1 pAb)后,我们对其交叉反应性进行了表征,并表明它不能通过流式细胞术识别其他家族受体(鼠 VPAC2 和 PAC1 以及人 VPAC1、VPAC2 和 PAC1)。兔α-VPAC1 血清的部分纯化将α-mVPAC1 pAb 的比活性提高了 20 倍,免疫荧光显微镜(IF)证实了鼠 VPAC1 蛋白的细胞膜亚细胞定位。为了测试这种特异性α-mVPAC1 pAb 的有用性,我们表明原代、静止的鼠 T 细胞表达可检测水平的 VPAC1 蛋白,而活化的 T 细胞或 CD19 B 细胞的信号很少可检测到。这些数据支持我们之前发表的数据,表明在 T 细胞激活过程中 VPAC1mRNA 下调。总的来说,我们已经建立了一种经过充分表征的、高度种属特异性的α-mVPAC1 pAb,可用于 IF 和流式细胞术测量 VPAC1 表面。